Significant positive correlations between the ACE activity and the levels of SBP (r = 0.459, P = 0.048) and DBP (r = 0.603, P = 0.005) were documented in patients with MS who did not receive any pharmacotherapy (group I). Here, ACE is linked to myeloid sarcoma.